Drug recall
Apheresis Platelets, Leukocytes Reduced
FDA recall event 83602 · Class II · Innovative Blood Resources
Key facts
| Event ID | 83602 |
|---|---|
| Recall numbers | B-0841-2019 |
| Recalling firm | Innovative Blood Resources |
| Product type | Biologics |
| Products | Apheresis Platelets, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Plateletpheresis product with a high white blood cell count, was distributed. |
| Initiation date | Apr 29, 2019 |
| Report date | Sep 4, 2019 |
| Termination date | Aug 29, 2019 |
| City | Saint Paul |
| State | MN |
| Country | United States |
| FEI number | 2170665 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: